💊🌟 PharmStars Is Open for Applications and Has BIG News!
PharmStars Announces “Rare Disease” Theme for 8th Cohort
PharmStarsTM, the pharma-focused accelerator for digital health startups, is now accepting applications for its Spring 2025 cohort which will be focused on “Digital Innovations in Rare Disease.” The PharmStars’ accelerator program is open to startups with solutions related to all aspects of rare disease drug development, treatment, and care. Startups with digital health innovations in any rare disease in any of the following areas are invited to apply by January 26:
Rare disease diagnosis and patient identification
Clinical trial design and execution for rare disease
Enhancing rare disease patient care
NEW THIS SPRING!! Funding for Startups
Starting in 2025, in addition to education, mentoring, and access to pharma clients, graduating startups will receive an investment of $150,000 from the PharmStars Ventures Fund. More information about this exciting new benefit can be found on the PharmStars website.
📆 Learn more and apply by January 26th